Mark Danta
Darlinghurst, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis.
Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis.
Journal: Frontiers in immunology
Published: March 10, 2025
Oral Microbial Diversity is Associated with Biologic Treatment and Metabolic Health Status but not with Disease Activity in Patients with Inflammatory Bowel Disease.
Journal: Crohn's & colitis 360
Published: March 06, 2025
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: February 27, 2025
Altered blood-brain barrier permeability is associated with abnormal distant connectivity and regional homogeneity in covert hepatic encephalopathy-A cross-sectional study.
Journal: Hepatology (Baltimore, Md.)
Published: December 09, 2024
Activation of the kynurenine pathway identified in individuals with covert hepatic encephalopathy.
Journal: Hepatology communications
Published: June 01, 2024
A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease.
Journal: British journal of clinical pharmacology
Published: April 10, 2024
Corrigendum to "Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales" [JHEP Reports 4 (2022)].
Journal: JHEP reports : innovation in hepatology
Published: March 14, 2024
Patient-driven personal importation in the face of cost barriers to care: can we do better?
Journal: Internal medicine journal
Published: February 26, 2024
The Role of the Gastrointestinal Microbiome in Liver Disease.
Journal: Pathogens (Basel, Switzerland)
Published: June 08, 2023
Last Updated: 09/26/2026